Clozapine and all‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study

OBJECTIVE: Large‐scale epidemiological studies have demonstrated a protective effect of clozapine on mortality in people with schizophrenia. Clozapine is reserved for use in patients with treatment‐resistant schizophrenia (TRS), but evidence of clozapine's effect on mortality exclusively within...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, J., Hayes, R. D., Jewell, A., Kadra, G., Shetty, H., MacCabe, J. H., Downs, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492259/
https://www.ncbi.nlm.nih.gov/pubmed/30478891
http://dx.doi.org/10.1111/acps.12989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492259/
https://www.ncbi.nlm.nih.gov/pubmed/30478891
http://dx.doi.org/10.1111/acps.12989

Ejemplares similares